{"transactions":[{"id":4637572,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-10-08T00:32:36.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":981,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2944,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":981},"source":{"system":"sec-edgar","filing":"0001952784-26-000003","document":"wk-form4_1791419553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1952784/000195278426000003/wk-form4_1791419553.xml","form_type":"4"}},{"id":4637571,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-10-08T00:32:36.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":981,"price":308.44,"value":302579.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026."}],"balance_after":4807,"source":{"system":"sec-edgar","filing":"0001952784-26-000003","document":"wk-form4_1791419553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1952784/000195278426000003/wk-form4_1791419553.xml","form_type":"4"}},{"id":4637570,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-10-08T00:32:36.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":981,"price":208.44,"value":204479.64,"ownership":{"direct":true},"balance_after":5788,"source":{"system":"sec-edgar","filing":"0001952784-26-000003","document":"wk-form4_1791419553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1952784/000195278426000003/wk-form4_1791419553.xml","form_type":"4"}},{"id":4633840,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-03T00:27:48.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":10,"price":297.43,"value":2974.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date.  The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period."}],"balance_after":27762,"source":{"system":"sec-edgar","filing":"0001100682-26-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000144/form4.xml","form_type":"4"}},{"id":674079,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-27T20:21:29.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":false,"shares":12429,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12429,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":12429},"source":{"system":"sec-edgar","filing":"0001100682-26-000140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/form4.xml","form_type":"4"}},{"id":674078,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-27T20:21:29.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":false,"shares":21132,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7044,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":21132},"source":{"system":"sec-edgar","filing":"0001100682-26-000140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/form4.xml","form_type":"4"}},{"id":674077,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T20:21:29.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":33561,"price":300,"value":10068300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026."}],"balance_after":31596,"source":{"system":"sec-edgar","filing":"0001100682-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/form4.xml","form_type":"4"}},{"id":674076,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T20:21:29.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":12429,"price":208.44,"value":2590700.76,"ownership":{"direct":true},"balance_after":65157,"source":{"system":"sec-edgar","filing":"0001100682-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/form4.xml","form_type":"4"}},{"id":674075,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-27T20:21:29.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":21132,"price":194.12,"value":4102143.84,"ownership":{"direct":true},"balance_after":52728,"source":{"system":"sec-edgar","filing":"0001100682-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/form4.xml","form_type":"4"}},{"id":680369,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:37:16.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":528,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35485,"source":{"system":"sec-edgar","filing":"0001100682-26-000138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000138/form4.xml","form_type":"4"}},{"id":680368,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-20T20:33:49.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":false,"shares":2039,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2039,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":2039},"source":{"system":"sec-edgar","filing":"0001100682-26-000136","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/form4.xml","form_type":"4"}},{"id":680367,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-08-20T20:33:49.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":2039,"price":294.12,"value":599710.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026."}],"balance_after":4807,"source":{"system":"sec-edgar","filing":"0001100682-26-000136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/form4.xml","form_type":"4"}},{"id":680366,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-08-20T20:33:49.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":true,"shares":2039,"price":194.12,"value":395810.68,"ownership":{"direct":true},"balance_after":6846,"source":{"system":"sec-edgar","filing":"0001100682-26-000136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/form4.xml","form_type":"4"}},{"id":680364,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":573,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":164.3,"exercise_date":"2021-03-02","expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":573},"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":680363,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":573,"price":285.24,"value":163442.52,"ownership":{"direct":true},"balance_after":1438,"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":680362,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":573,"price":164.3,"value":94143.9,"ownership":{"direct":true},"balance_after":2011,"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":688274,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":688273,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":279.9,"value":1819350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 3, 2025."}],"balance_after":36013,"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":688272,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-13T20:37:36.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":179.66,"value":1167790.0,"ownership":{"direct":true},"balance_after":42513,"source":{"system":"sec-edgar","filing":"0001100682-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/form4.xml","form_type":"4"}},{"id":688271,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-13T20:34:15.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":3714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":3714},"source":{"system":"sec-edgar","filing":"0001100682-26-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000130/form4.xml","form_type":"4"}},{"id":688270,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-08-13T20:34:15.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":3714,"price":279.66,"value":1038657.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026."}],"balance_after":4807,"source":{"system":"sec-edgar","filing":"0001100682-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000130/form4.xml","form_type":"4"}},{"id":688269,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-08-13T20:34:15.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":3714,"price":179.66,"value":667257.24,"ownership":{"direct":true},"balance_after":8521,"source":{"system":"sec-edgar","filing":"0001100682-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000130/form4.xml","form_type":"4"}},{"id":691189,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-08-11T20:38:49.000Z","date":"2026-08-10","kind":"gift","planned":false,"acquired":false,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31041,"source":{"system":"sec-edgar","filing":"0001100682-26-000128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000128/form4.xml","form_type":"4"}},{"id":691188,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-11T20:35:50.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":28733,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":28733},"source":{"system":"sec-edgar","filing":"0001100682-26-000126","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000126/form4.xml","form_type":"4"}},{"id":691187,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T20:35:50.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":28733,"price":275,"value":7901575.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026."}],"balance_after":31596,"source":{"system":"sec-edgar","filing":"0001100682-26-000126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000126/form4.xml","form_type":"4"}},{"id":691186,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T20:35:50.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":28733,"price":179.66,"value":5162170.78,"ownership":{"direct":true},"balance_after":60329,"source":{"system":"sec-edgar","filing":"0001100682-26-000126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000126/form4.xml","form_type":"4"}},{"id":692181,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":736,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":736},"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692180,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1205,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":402,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":1205},"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692179,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":404},"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692178,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":736,"price":258.53,"value":190278.08,"ownership":{"direct":true},"balance_after":11852,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692177,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1205,"price":258.53,"value":311528.65,"ownership":{"direct":true},"balance_after":12588,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692176,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":404,"price":258.53,"value":104446.12,"ownership":{"direct":true},"balance_after":13793,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692175,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":736,"price":208.44,"value":153411.84,"ownership":{"direct":true},"balance_after":14197,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692174,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1205,"price":194.12,"value":233914.6,"ownership":{"direct":true},"balance_after":13461,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692173,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":404,"price":179.66,"value":72582.64,"ownership":{"direct":true},"balance_after":12256,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692172,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":482,"price":265.17,"value":127811.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $264.91 to $265.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11852,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692171,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":620,"price":263.94,"value":163642.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $263.39 to $264.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12334,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692170,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":213,"price":262.37,"value":55884.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $262.26 to $262.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12954,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692169,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":810,"price":261.45,"value":211774.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $261.00 to $261.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13167,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692168,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":901,"price":260.63,"value":234827.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $259.97 to $260.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13977,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692167,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-08-10T20:40:15.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1274,"price":259.07,"value":330055.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $258.77 to $259.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14878,"source":{"system":"sec-edgar","filing":"0001100682-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/form4.xml","form_type":"4"}},{"id":692164,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-10T20:35:30.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":4179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":4179},"source":{"system":"sec-edgar","filing":"0001100682-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000122/form4.xml","form_type":"4"}},{"id":692163,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-08-10T20:35:30.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":4179,"price":259.16,"value":1083029.64,"ownership":{"direct":true},"balance_after":30051,"source":{"system":"sec-edgar","filing":"0001100682-26-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000122/form4.xml","form_type":"4"}},{"id":692162,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-08-10T20:35:30.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":4179,"price":179.66,"value":750799.14,"ownership":{"direct":true},"balance_after":34230,"source":{"system":"sec-edgar","filing":"0001100682-26-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000122/form4.xml","form_type":"4"}},{"id":694471,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-08-06T20:49:12.000Z","date":"2026-08-05","kind":"sale","planned":true,"acquired":false,"shares":5046,"price":263,"value":1327098.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026."}],"balance_after":4807,"source":{"system":"sec-edgar","filing":"0001100682-26-000120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000120/form4.xml","form_type":"4"}},{"id":721742,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-01T20:59:29.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":225,"value":16875000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted by the reporting person on March 6, 2026."}],"balance_after":31596,"source":{"system":"sec-edgar","filing":"0001100682-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000111/form4.xml","form_type":"4"}},{"id":746688,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust Held By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 10,000 shares held by the reporting person's spouse to a revocable trust controlled by the reporting person's spouse."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746687,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 10,000 shares held by the reporting person's spouse to a revocable trust controlled by the reporting person's spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746686,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2026 GRAT"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 20,000 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746685,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 20,000 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":106596,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746684,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":153361,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":155611,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746683,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-08T20:25:39.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":153361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":126596,"source":{"system":"sec-edgar","filing":"0001100682-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000109/form4.xml","form_type":"4"}},{"id":746682,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:21:53.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":3386,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":43803,"source":{"system":"sec-edgar","filing":"0001100682-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000107/form4.xml","form_type":"4"}},{"id":746681,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:21:53.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":3386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":36013,"source":{"system":"sec-edgar","filing":"0001100682-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000107/form4.xml","form_type":"4"}},{"id":746680,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-06-08T20:19:14.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":true,"shares":1529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":9680,"source":{"system":"sec-edgar","filing":"0001100682-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000105/form4.xml","form_type":"4"}},{"id":746679,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-06-08T20:19:14.000Z","date":"2026-06-05","kind":"gift","planned":false,"acquired":false,"shares":1529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":9853,"source":{"system":"sec-edgar","filing":"0001100682-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000105/form4.xml","form_type":"4"}},{"id":753270,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42043,"kind":"person","name":"Barg Steven","position":1,"cik":"0001852883","reported_name":"Barg Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-04T01:45:20.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":422,"price":174.79,"value":73761.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant was made in lieu of director service fees for the term commencing May 5, 2026. The restricted stock units vest upon the earlier of 6/2/2027, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":3287,"source":{"system":"sec-edgar","filing":"0001100682-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852883/000110068226000103/form4.xml","form_type":"4"}},{"id":755534,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:46:05.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":6640,"price":180.71,"value":1199914.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030."}],"balance_after":27752,"source":{"system":"sec-edgar","filing":"0001100682-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000101/form4.xml","form_type":"4"}},{"id":755533,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42511,"kind":"person","name":"Mintz Mark","position":1,"cik":"0002071546","reported_name":"Mintz Mark","relationship":{"officer":true,"officer_title":"EVP, Chief Information Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:42:55.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":64,"price":180.71,"value":11565.44,"ownership":{"direct":true},"balance_after":9546,"source":{"system":"sec-edgar","filing":"0001100682-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000099/form4.xml","form_type":"4"}},{"id":755532,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42511,"kind":"person","name":"Mintz Mark","position":1,"cik":"0002071546","reported_name":"Mintz Mark","relationship":{"officer":true,"officer_title":"EVP, Chief Information Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:42:55.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":305,"price":180.71,"value":55116.55,"ownership":{"direct":true},"balance_after":9610,"source":{"system":"sec-edgar","filing":"0001100682-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000099/form4.xml","form_type":"4"}},{"id":755531,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42511,"kind":"person","name":"Mintz Mark","position":1,"cik":"0002071546","reported_name":"Mintz Mark","relationship":{"officer":true,"officer_title":"EVP, Chief Information Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:42:55.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2534,"price":180.71,"value":457919.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":9915,"source":{"system":"sec-edgar","filing":"0001100682-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000099/form4.xml","form_type":"4"}},{"id":755530,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":235,"price":180.71,"value":42466.85,"ownership":{"direct":true},"balance_after":31298,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":755529,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":744,"price":180.71,"value":134448.24,"ownership":{"direct":true},"balance_after":31533,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":755528,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5257,"price":180.71,"value":949992.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":32277,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":755527,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-06-02T20:37:41.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":48,"price":180.71,"value":8674.08,"ownership":{"direct":true},"balance_after":16152,"source":{"system":"sec-edgar","filing":"0001100682-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000095/form4.xml","form_type":"4"}},{"id":755526,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-06-02T20:37:41.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":152,"price":180.71,"value":27467.92,"ownership":{"direct":true},"balance_after":16200,"source":{"system":"sec-edgar","filing":"0001100682-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000095/form4.xml","form_type":"4"}},{"id":755525,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-06-02T20:37:41.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":1837,"price":180.71,"value":331964.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":16352,"source":{"system":"sec-edgar","filing":"0001100682-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000095/form4.xml","form_type":"4"}},{"id":755524,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":378,"price":180.71,"value":68308.38,"ownership":{"direct":true},"balance_after":39399,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":755523,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1204,"price":180.71,"value":217574.84,"ownership":{"direct":true},"balance_after":39777,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":755522,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:35:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9961,"price":180.71,"value":1800052.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":40981,"source":{"system":"sec-edgar","filing":"0001100682-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000093/form4.xml","form_type":"4"}},{"id":755521,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19163,"kind":"person","name":"FOSTER JAMES C","position":1,"cik":"0001141722","reported_name":"FOSTER JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:31:04.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1596,"price":180.71,"value":288413.16,"ownership":{"direct":true},"balance_after":279957,"source":{"system":"sec-edgar","filing":"0001100682-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000091/form4.xml","form_type":"4"}},{"id":755520,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:27:29.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":194,"price":180.71,"value":35057.74,"ownership":{"direct":true},"balance_after":30051,"source":{"system":"sec-edgar","filing":"0001100682-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000089/form4.xml","form_type":"4"}},{"id":755519,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:27:29.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":180.71,"value":111317.36,"ownership":{"direct":true},"balance_after":30245,"source":{"system":"sec-edgar","filing":"0001100682-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000089/form4.xml","form_type":"4"}},{"id":755518,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:27:29.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5135,"price":180.71,"value":927945.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":30861,"source":{"system":"sec-edgar","filing":"0001100682-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000089/form4.xml","form_type":"4"}},{"id":755517,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-06-02T20:25:14.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":170,"price":180.71,"value":30720.7,"ownership":{"direct":true},"balance_after":11382,"source":{"system":"sec-edgar","filing":"0001100682-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000087/form4.xml","form_type":"4"}},{"id":755516,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-06-02T20:25:14.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":551,"price":180.71,"value":99571.21,"ownership":{"direct":true},"balance_after":11552,"source":{"system":"sec-edgar","filing":"0001100682-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000087/form4.xml","form_type":"4"}},{"id":755515,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-06-02T20:25:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":4361,"price":180.71,"value":788076.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":12103,"source":{"system":"sec-edgar","filing":"0001100682-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000087/form4.xml","form_type":"4"}},{"id":760607,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:43:15.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":148,"price":156.73,"value":23196.04,"ownership":{"direct":true},"balance_after":25726,"source":{"system":"sec-edgar","filing":"0001100682-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000085/form4.xml","form_type":"4"}},{"id":760606,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25129,"kind":"person","name":"Creamer Victoria L","position":1,"cik":"0001632780","reported_name":"Creamer Victoria L","relationship":{"officer":true,"officer_title":"EVP & Chief People Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:43:15.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":198,"price":160.3,"value":31739.4,"ownership":{"direct":true},"balance_after":25874,"source":{"system":"sec-edgar","filing":"0001100682-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000085/form4.xml","form_type":"4"}},{"id":760605,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-05-28T20:39:46.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":105,"price":156.73,"value":16456.65,"ownership":{"direct":true},"balance_after":7742,"source":{"system":"sec-edgar","filing":"0001100682-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000083/form4.xml","form_type":"4"}},{"id":760604,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-05-28T20:39:46.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":168,"price":160.3,"value":26930.4,"ownership":{"direct":true},"balance_after":7847,"source":{"system":"sec-edgar","filing":"0001100682-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000083/form4.xml","form_type":"4"}},{"id":760603,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-05-28T20:39:46.000Z","date":"2026-02-06","kind":"gift","planned":false,"acquired":true,"shares":7169,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 7,169 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":8151,"source":{"system":"sec-edgar","filing":"0001100682-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000083/form4.xml","form_type":"4"}},{"id":760602,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21333,"kind":"person","name":"Parisotto Shannon M","position":1,"cik":"0001952784","reported_name":"Parisotto Shannon M","relationship":{"officer":true,"officer_title":"CEVP, Disc & Safety Assessment"}}],"security":"Common Stock","published_at":"2026-05-28T20:39:46.000Z","date":"2026-02-06","kind":"gift","planned":false,"acquired":false,"shares":7169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 7,169 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":8015,"source":{"system":"sec-edgar","filing":"0001100682-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000083/form4.xml","form_type":"4"}},{"id":760601,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42511,"kind":"person","name":"Mintz Mark","position":1,"cik":"0002071546","reported_name":"Mintz Mark","relationship":{"officer":true,"officer_title":"EVP, Chief Information Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:36:18.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":47,"price":156.73,"value":7366.31,"ownership":{"direct":true},"balance_after":7381,"source":{"system":"sec-edgar","filing":"0001100682-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000081/form4.xml","form_type":"4"}},{"id":760600,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42511,"kind":"person","name":"Mintz Mark","position":1,"cik":"0002071546","reported_name":"Mintz Mark","relationship":{"officer":true,"officer_title":"EVP, Chief Information Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:36:18.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":64,"price":160.3,"value":10259.2,"ownership":{"direct":true},"balance_after":7428,"source":{"system":"sec-edgar","filing":"0001100682-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000081/form4.xml","form_type":"4"}},{"id":760599,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:03.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":242,"price":156.73,"value":37928.66,"ownership":{"direct":true},"balance_after":31020,"source":{"system":"sec-edgar","filing":"0001100682-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000079/form4.xml","form_type":"4"}},{"id":760598,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21334,"kind":"person","name":"Girshick Birgit","position":1,"cik":"0001732091","reported_name":"Girshick Birgit","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:03.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":376,"price":160.3,"value":60272.8,"ownership":{"direct":true},"balance_after":31262,"source":{"system":"sec-edgar","filing":"0001100682-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000079/form4.xml","form_type":"4"}},{"id":760597,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-05-28T20:27:43.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":156.73,"value":5799.01,"ownership":{"direct":true},"balance_after":14515,"source":{"system":"sec-edgar","filing":"0001100682-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000077/form4.xml","form_type":"4"}},{"id":760596,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":25131,"kind":"person","name":"Knell Michael Gunnar","position":1,"cik":"0001543779","reported_name":"Knell Michael Gunnar","relationship":{"officer":true,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2026-05-28T20:27:43.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":50,"price":160.3,"value":8015.0,"ownership":{"direct":true},"balance_after":14552,"source":{"system":"sec-edgar","filing":"0001100682-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000077/form4.xml","form_type":"4"}},{"id":760594,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-05-28T20:24:53.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":185,"price":156.73,"value":28995.05,"ownership":{"direct":true},"balance_after":27020,"source":{"system":"sec-edgar","filing":"0001100682-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000075/form4.xml","form_type":"4"}},{"id":760593,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-05-28T20:24:53.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":160.3,"value":38952.9,"ownership":{"direct":true},"balance_after":27205,"source":{"system":"sec-edgar","filing":"0001100682-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000075/form4.xml","form_type":"4"}},{"id":779676,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-14T21:11:40.000Z","date":"2026-05-12","kind":"gift","planned":false,"acquired":true,"shares":3964,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":3964,"source":{"system":"sec-edgar","filing":"0001100682-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000073/form4.xml","form_type":"4"}},{"id":779675,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-14T21:11:40.000Z","date":"2026-05-12","kind":"gift","planned":false,"acquired":false,"shares":3964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":1438,"source":{"system":"sec-edgar","filing":"0001100682-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000073/form4.xml","form_type":"4"}},{"id":783405,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42043,"kind":"person","name":"Barg Steven","position":1,"cik":"0001852883","reported_name":"Barg Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-12T21:14:47.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2865,"source":{"system":"sec-edgar","filing":"0001100682-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852883/000110068226000071/form4.xml","form_type":"4"}},{"id":783040,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-12T20:22:11.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":3851,"source":{"system":"sec-edgar","filing":"0001100682-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000068/form4.xml","form_type":"4"}},{"id":783041,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":48073,"kind":"person","name":"Graves Paul W","position":1,"cik":"0001559551","reported_name":"Graves Paul W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-12T20:19:51.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2384,"source":{"system":"sec-edgar","filing":"0001100682-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000066/form4.xml","form_type":"4"}},{"id":785215,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":19566,"kind":"person","name":"Ceesay Abraham","position":1,"cik":"0001722140","reported_name":"Ceesay Abraham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-11T20:51:41.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2384,"source":{"system":"sec-edgar","filing":"0001100682-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000062/form4.xml","form_type":"4"}},{"id":785214,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":16976,"kind":"person","name":"MACKAY MARTIN","position":1,"cik":"0001414815","reported_name":"MACKAY MARTIN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-11T20:48:31.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1407,"price":177.62,"value":249911.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The grant was made in lieu of director service fees for the term commencing May 5, 2026. The restricted stock units vest upon the earlier of 5/8/2027, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":17137,"source":{"system":"sec-edgar","filing":"0001100682-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000059/form4.xml","form_type":"4"}},{"id":785213,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":16976,"kind":"person","name":"MACKAY MARTIN","position":1,"cik":"0001414815","reported_name":"MACKAY MARTIN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-11T20:48:31.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":15730,"source":{"system":"sec-edgar","filing":"0001100682-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000059/form4.xml","form_type":"4"}},{"id":785212,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-11T20:45:56.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":5402,"source":{"system":"sec-edgar","filing":"0001100682-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000057/form4.xml","form_type":"4"}}],"next_cursor":"2026-05-11T20:45:56.000000Z,785212"}